Senior insider sale
Chief Operating Officer at BICYCLE THERAPEUTICS PLC — senior position signals high conviction
$58.1K
9.51K shares
What this filing means
MILNES ALISTAIR plans to sell 9.51K shares of BICYCLE THERAPEUTICS PLC valued at approximately $58.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001972481-26-000130
Officer· Chief Operating Officer
Since Jan 2022
9.51K
Shares to sell
$58.1K
Approx. market value
5.72K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Restricted Stock
Equity Compensation
4/3/2026
1.09KRestricted Stock
Equity Compensation
4/2/2026
4.62KTotal acquired5.72K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/3/2026 | Restricted Stock Equity Compensation | 1.09K | — |
4/2/2026 | Restricted Stock Equity Compensation | 4.62K | — |
| Total | 5.72K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.24K
Market value
$22.1K
4/2/2026
—Completed
Units to sell
3.42K
Market value
$22.1K
1/5/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.85K
Market value
$14.0K
4/2/2026
Total
Units
9.51K
Value
$58.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/2/2026 | 3.24K | $22.1K | — | Completed |
1/5/2026 | 3.42K | $22.1K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 2.85K | $14.0K | Nasdaq | Planned |
| Total | 9.51K | $58.1K | ||